The entertainment empire began with Liu Yifei's premarital pregnancy.

[Ding, host, would you like to open the Dragon Head Raising Festival gift pack?]

【whether】

"System, open the holiday gift pack!"

After entering the study, Lin Bufan sat down in a chair.

[Ding! Congratulations, host! You have opened the Dragon Head Raising Festival gift pack and received the reward: Biodegradable Occlusion Technology]

"What is this?"

Lin Bufan listened to the explanation in his mind and was somewhat puzzled.

He realized that since the system upgrade, the sign-in technology was completely incomprehensible from the name alone.

As the system's voice faded, a stack of documents appeared out of thin air on the table in front of Lin Bufan.

Looking at the stack of documents on the table, Lin Bufan curiously flipped through them.

An hour later, Lin Bufan closed the documents, a glint of light flashing in his eyes.

He now knows what biodegradable plugging technology is.

In simple terms, this is a medical device for treating congenital heart disease. Currently, it is used worldwide to treat congenital heart disease, especially the three types: ventricular septal defect (VSD), atrial septal defect (ASD), and patent ductus arteriosus (PDA).

Occluders are needed for treatment, and currently, nickel-titanium alloy occluders are the most commonly used technology worldwide.

However, there is a problem: the nickel-titanium alloy occluder will remain in the body for life, and long-term use may lead to nickel allergy or poisoning.

Furthermore, because the nickel-titanium alloy is attached to the atrial wall, it can easily lead to atrial arrhythmias and even thrombus formation related to the occluder.

In rare cases, conduction block may occur, which may even affect the path of future interventional surgeries.

Furthermore, some patients who cannot tolerate it require a second open-chest surgery to remove the nickel-titanium alloy occluder. Of course, the probability is very low, only about 0.2%, roughly one in five hundred patients.

The technology currently used in the world is semi-degradable. The skeleton of the occluder is made of nickel-cobalt-chromium-molybdenum alloy, which is non-degradable, while the flow-blocking membrane is made of degradable porcine type I collagen membrane.

This semi-biodegradable occluder is much more effective than the non-biodegradable one, but it still carries a significant risk of requiring a second open-chest surgery.

The biodegradable plugging device technology that Lin Bufan just signed up for.

The skeleton and flow barrier membrane are made using some synthetic materials, so there is no need to worry about metal remaining in the body after the surgery.

The occluder will degrade within the body over 2-3 years.

To give a simple example, these heart diseases are like a "wound" in the heart, and the principle of the occluder is to plug this wound.

Previously, nickel-titanium alloy plugs were used, so they had to be kept in place.

The technology Lin Bufan used to sign in, after sealing the "wound," assists the body's own repair function. After 2-3 years, during this degradation process, the heart has successfully repaired itself.

At the same time, this biodegradable occluder will also be excreted from the body through breathing and urine.

"System, you're so understanding!"

Lin Bufan simply put the documents away.

The foundation and the children's hospital had just been established when they secured this technology, which has a high success rate in treating congenital heart disease.

These three types of congenital heart disease account for 65% of all congenital heart disease cases. Simply put, out of 100,000 patients, 65,000 will have one of these three conditions.

"but……"

Lin Bufan had a slight thought: perhaps it was time to establish a company that manufactures medical devices.

The self-healing hydrogel technology from last time can also be used to assist in surgery, in addition to this biodegradable occluder technology.

……

"Hello, Mr. Leon!"

In the VIP reception room on the 30th floor of the Kyoto Building, Lin Bufan met the renowned Leonardo DiCaprio.

"Director Lin, hello!"

Little Li greeted Lin Bufan in the Chinese he had just learned.

In terms of interpersonal relationships and social etiquette, this applies not only domestically but globally. If you insist that it doesn't exist abroad, then it just means you're not yet qualified to engage with those aspects.

"Mr. Leon..."

"Director Lin, you can just call me Leon!"

Lin Bufan had only spoken halfway when Xiao Li interrupted him.

It's true that Leonardo DiCaprio has a huge influence in Hollywood, but Lin Bufan's status is even higher, not only because directors are more important than actors, but also because of Extraordinary Film Company.

Everyone in Hollywood knows that Extraordinary Film Company is number one, second only to the Big Six.

Moreover, there are rumors that Extraordinary Film Company may become the seventh largest in Hollywood.

Just last night, Bart Elvis reported to Lin Bufan over the phone that Goldman Sachs, Citigroup, and Merrill Lynch had acquired a stake in Extraordinary Film Company.

The shareholding structure of Extraordinary Film Company has changed significantly.

According to the valuations of Goldman Sachs, Citigroup, and Merrill Lynch, the entire Extraordinary Film Company was valued at $5 million.

Goldman Sachs invested $5000 million to acquire a 10% stake in Extraordinary Film Company.

Citigroup and Merrill Lynch each invested $4000 million, holding an 8% stake.

Strong Wind Investment holds 30% of the shares, and Lin Bufan holds 10%.

The largest shareholder is Strong Wind Investment, holding 30% of the shares. The second largest shareholders are Goldman Sachs and Lin Bufan, each holding 10%, and finally Citigroup and Merrill Lynch, each holding 8%.

The remaining 34% of the shares are held by various institutions and private individuals, ranging from 1% to 0.1%.

Of course, this is the official statement. In reality, the remaining 34% of the shares are all in Lin Bufan's hands, but they are being held on his behalf.

With the help of Goldman Sachs, Citigroup, and Merrill Lynch, Extraordinary Film Company was accepted by the six major Hollywood studios and joined the DCI organization.

However, there are still some procedures to go through.

Once Extraordinary Film Company goes public, DCI will announce this, which will likely boost the stock price.

This is why Lin Bufan openly owns 10% of Extraordinary Film Company, which means he's practically a player in Hollywood.